Gujarat Themis Biosyn Ltd
BSE:506879
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Gujarat Themis Biosyn Ltd
BSE:506879
|
IN |
|
Crcc High-Tech Equipment Corp Ltd
HKEX:1786
|
CN |
|
Kewell Technology Co Ltd
SSE:688551
|
CN |
|
GTL Ltd
NSE:GTL
|
IN |
|
C
|
CHTC Helon Co Ltd
SZSE:000677
|
CN |
|
ICO Group Ltd
HKEX:1460
|
HK |
|
R
|
Royal Orchid Hotel Thailand PCL
SET:ROH
|
TH |
|
P
|
PACS Group Inc
NYSE:PACS
|
US |
|
T
|
Teck Resources Ltd
TSX:TECK.A
|
CA |
|
Walker Crips Group PLC
LSE:WCW
|
UK |
|
P
|
POWR Lithium Corp
CNSX:POWR
|
CA |
|
S
|
Sjova-Almennar tryggingar hf
ICEX:SJOVA
|
IS |
|
S
|
SMIFS Capital Markets Ltd
BSE:508905
|
IN |
|
E
|
Erste Group Bank AG
XMUN:EBO
|
AT |
|
Clear Sale SA
BOVESPA:CLSA3
|
BR |
|
City Pub Group PLC
LSE:CPC
|
UK |
|
T
|
Terna Energy SA
ATHEX:TENERGY
|
GR |
|
C
|
Creepy Jar SA
WSE:CRJ
|
PL |
Bankruptcy Probability
Gujarat Themis Biosyn Ltd's probability of bankruptcy is hidden . The solvency score is hidden .
We take all the information about a company's solvency (such as how easily a company can pay interest on its outstanding debt, how much cash it has, the amount of debt, and more) and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Gujarat Themis Biosyn Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| IN |
|
Gujarat Themis Biosyn Ltd
BSE:506879
|
28.7B INR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
879.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
574.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
232B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
295.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
236.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
154.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
116.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Gujarat Themis Biosyn Ltd's probability of bankruptcy is hidden .
The probability of bankruptcy is estimated using credit risk models that assess its financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Gujarat Themis Biosyn Ltd has total debt of 700.3m INR. This includes both short-term (0 INR) and long-term (700.3m INR) debt.
You can find a full breakdown on its Balance Sheet.
